CN107582805A - One kind controls beriberi - Google Patents
One kind controls beriberi Download PDFInfo
- Publication number
- CN107582805A CN107582805A CN201710978962.8A CN201710978962A CN107582805A CN 107582805 A CN107582805 A CN 107582805A CN 201710978962 A CN201710978962 A CN 201710978962A CN 107582805 A CN107582805 A CN 107582805A
- Authority
- CN
- China
- Prior art keywords
- parts
- bulk drug
- beriberi
- radix
- foot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to one kind to control beriberi medicament, and it is made up of the bulk drug of following weight:20 parts of cape jasmine 10 part, 30 parts of toddalia 10 part, 15 parts of bitter orange 10 part, 15 25 parts of Radix Liriopes, 20 parts of asarum 10 part, windproof 15 parts 25 parts, 25 parts of the root of Dahurain angelica 10 part, 30 parts of radix aconiti agrestis 20 part, 20 parts of Radix Angelicae Sinensis 10 part, 30 parts of Ligusticum wallichii 10 part, 20 parts of peppermint 10 part, 30 parts of frankincense 20 part.The beneficial effects of the invention are as follows:Bulk drug wide material sources, it is cheap and be easy to buy, foot fungi can be reduced and produced, fungal infection can be eliminated, can treating beriberi, have analgesic effect, it can prevent that patient from being rubbed foot due to pain, the skin for avoiding patient is ruptured due to friction, avoids fungal infection, tinea pedis can quickly be removed, reduce treatment time, therapeutic process can be shortened, therapeutic effect is obvious, cure rate is high, uneasy to recur.
Description
Technical field
The invention belongs to field of medicaments, especially one kind to control beriberi.
Background technology
Tinea pedis is a kind of common fungal infectious disease, and 70%-80% people has tinea pedis in adult, and weight is different, leads to
Often aggravate, mitigate in the winter time, also someone is not cured throughout the year in summer.The pathogenesis of tinea pedis is:Tinea pedis is by contagion.Due to
The palm, plantar epidermal cell substitute time length, and cutin thickness, sweat gland is more, and without sebaceous glands, and biped often wears footgear, it is close not
Ventilative, sweat evaporation is difficult, is allowed to local temperature height, high humidity, cuticula often impregnated softening, the change of epidermis acid-base value, satisfies
Good condition is created for fungi growth.In addition, personal hygiene custom is bad, contact the footgear of patient, gloves, share slippers,
Towel and bathing pool etc., then it is easy to be infected.Dermatophyte is usually through the publilc baths of the pollution, floor of edge of pool, bath towel, public
Slippers, foot basin and infect.The pathogenic factor of tinea pedis is:Pathogenic bacteria polyphyly trichophyton and Epidermophyton kind, main bacteria seed have
Trichophyton rubrum, trichophyton gypseum, acrothesium floccosum, trichophyton meginii.Trichophyton rubrum is not easy because its resistance is strong
Control, it has also become the Main Pathogenic Bacteria of the current tinea pedis in China.
The harm of tinea pedis is:
1. tinea pedis can cause acute lymphangitis, simply a kind of common inflammation, when macerative erosive either vesicle
Beriberi infection suppurate when be easy to cause acute lymphangitis.
2. tinea pedis causes erysipelas, so-called erysipelas is exactly a kind of inflammation caused by tinea pedis, and the traditional Chinese medical science is referred to as filariasis, and patient is past
It is hurried toward onset, patient is cold, heating, nausea etc. symptom, body temperature may be to 39 degree, leucocyte raises.Lighter patient is only
There is transient erythema in ankle and foot skin, a few patients may occur in which local tissue necrosis.Elderly and infirm, kidney can also occur
The complication such as scorching, subcutaneous abscess and septicemia.
3. celluar tissue, this is also one of inflammation caused by tinea pedis, and general disease hair removes to be removed for the illness of tinea pedis, the ground of infection
Square soft tissue is loose, and inflammation can spread to surrounding, or even can feed through to the tissue in deep, reach osseous part, can draw when serious
Play blister.Generally, abscess occurs in celluar tissue within the time of one week, can also cause angioleucitis and sepsis
Disease.
The medicine that in the market is used to treat tinea pedis has a lot, but these common medicine general therapeutic effects are poor, control
More rate is relatively low, treatment time length, easy recurrent exerbation.
The content of the invention
The shortcomings that present invention is directed to above-mentioned prior art, there is provided one kind controls beriberi, and cost is low, and therapeutic effect is obvious,
Treatment time is short, and cure rate is high, and therapeutic effect is thorough, uneasy to recur.
The present invention solves the technical scheme that its technical problem uses:This medicine for controlling tinea pedis, it is characterised in that it be by
The bulk drug of following weight is made:10 parts -20 parts of cape jasmine, 10 parts -30 parts of toddalia, 10 parts -15 parts of bitter orange, mountain wheat
15 parts -25 parts of winter, 10 parts -20 parts of asarum, windproof 15 parts -25 parts, 10 parts -25 parts of the root of Dahurain angelica, 20 parts -30 parts of radix aconiti agrestis, 10 parts of Radix Angelicae Sinensis -
20 parts, 10 parts -30 parts of Ligusticum wallichii, 10 parts -20 parts of peppermint, 20 parts -30 parts of frankincense.
The dosage of above-mentioned each bulk drug is that it is made up of the bulk drug of following weight:15 parts of cape jasmine, the flying dragon palm
20 parts of blood, 15 parts of bitter orange, 20 parts of Radix Liriopes, 18 parts of asarum, windproof 22 parts, 16 parts of the root of Dahurain angelica, 16 parts of radix aconiti agrestis, 18 parts of Radix Angelicae Sinensis, Ligusticum wallichii
24 parts, 18 parts of peppermint, 30 parts of frankincense.
The preparation method of this medicine is:Weighed by the bulk drug of above-mentioned weight, mixing is smashed to pieces, mixed after smashing to pieces
Close bulk drug to insert in marmite, 2000 grams -3000 grams of water is added in marmite, it is small that 2 are decocted at a temperature of 70 DEG C~90 DEG C
When -4 hours, the juice of bulk drug is obtained after filtering, is produced after its cooling and controls beriberi.
Cape jasmine:Property it is bitter, cold, have purging intense heat and detonicating, clearing heat and promoting diuresis, cool blood dissipates the stasis of blood, to treatment tinea pedis have special result;
Toddalia:Toddalia has dissipate stasis of blood hemostasis, dispelling wind and eliminating dampness, the effect of subdhing swelling and detoxicating;
Bitter orange:Property bitter, temperature, there is the effect of qi-regulating;
Radix Liriopes:It is slightly cold, is sweet, slight bitter, the effect with nourishing Yin and promoting production of body fluid;
Asarum:It is warm-natured, pungent, there is expelling wind and clearing away cold, sensible analgesic, the effect of Wenfei of drink;
It is windproof:It is tepor, pungent, sweet, have that inducing diaphoresis to dispel wind, victory be wet, effect of only convulsion;
The root of Dahurain angelica:It is warm-natured, pungent, have and dissipate wind dehumidifying, sensible analgesic, the effect of detumescence and apocenosis;
Radix aconiti agrestis:Property it is hot, pungent, bitter, have dispelling wind and eliminating dampness, the effect of antalgic;
Radix Angelicae Sinensis:It is warm-natured, sweet, pungent, there is replenishing and activating blood, the effect of menstruction regulating and pain relieving;
Ligusticum wallichii:It is warm-natured, pungent, there is blood-activating and qi-promoting, the effect of wind-expelling pain-stopping;
Peppermint:Cool in nature, good fortune, has the effect of fine to diseases such as skin rubella itching, measless without adequate eruption,
In addition it is also effective to carbuncle, subcutaneous ulcer, scabies, tinea, dermatitis rhus;
Frankincense:It is warm-natured, pungent, bitter, there is blood-activating and qi-promoting analgesic, the effect of detumescence and promoting granulation.
The bulk drug that the present invention selects, there is the effect invigorating blood circulation, stop blooding, enriching blood, beneficial to foot's vim and vigour circulation, supplement foot
Qi and blood, the activity of increase foot cell, beneficial to Skin Cell activity, reduce fungi and produce;The bulk drug that the present invention selects, has
Subdhing swelling and detoxicating, dispelling wind and eliminating dampness, the fungi activity of foot can be eliminated, protects foot's skin by fungal infection, not reduce and infect;This hair
The bulk drug of bright selection, there is the effect of analgesic, patient's friction foot can be prevented, avoid skin from fraying, reduce fungal infection.
The beneficial effects of the invention are as follows:Bulk drug wide material sources, it is cheap and be easy to buy, foot fungi can be reduced
Produce, fungal infection can be eliminated, can treating beriberi, have analgesic effect, can prevent patient from being rubbed due to pain
Foot, the skin for avoiding patient are ruptured due to friction, avoid fungal infection, can quickly be removed tinea pedis, be reduced and control
The time is treated, therapeutic process can be shortened, therapeutic effect is obvious, and cure rate is high, uneasy to recur.
Claims (3)
1. one kind controls beriberi, it is characterised in that it is made up of the bulk drug of following weight:10 part -20 of cape jasmine
It is part, 10 parts -30 parts of toddalia, 10 parts -15 parts of bitter orange, 15 parts -25 parts of Radix Liriopes, 10 parts -20 parts of asarum, windproof 15 part -25
Part, 10 parts -25 parts of the root of Dahurain angelica, 20 parts -30 parts of radix aconiti agrestis, 10 parts -20 parts of Radix Angelicae Sinensis, 10 parts -30 parts of Ligusticum wallichii, 10 parts -20 parts of peppermint, frankincense
20 parts -30 parts.
2. according to claim 1 control beriberi, it is characterised in that it is by the bulk drug system of following weight
Into:15 parts of cape jasmine, 20 parts of toddalia, 15 parts of bitter orange, 20 parts of Radix Liriopes, 18 parts of asarum, windproof 22 parts, 16 parts of the root of Dahurain angelica, radix aconiti agrestis
16 parts, 18 parts of Radix Angelicae Sinensis, 24 parts of Ligusticum wallichii, 18 parts of peppermint, 30 parts of frankincense.
3. the preparation method according to claim 1 or 2 for controlling beriberi, it is characterised in that:By above-mentioned weight
Bulk drug weigh, mixing is smashed to pieces, and the mixed material medicine after smashing to pieces is inserted in medicine pot, in marmite add 2000 gram -3000
Gram water, decocted -4 hours 2 hours at a temperature of 70 DEG C~90 DEG C, the juice of bulk drug obtained after filtering, after its cooling after
Produce and control beriberi.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710978962.8A CN107582805A (en) | 2017-10-19 | 2017-10-19 | One kind controls beriberi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710978962.8A CN107582805A (en) | 2017-10-19 | 2017-10-19 | One kind controls beriberi |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107582805A true CN107582805A (en) | 2018-01-16 |
Family
ID=61053648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710978962.8A Pending CN107582805A (en) | 2017-10-19 | 2017-10-19 | One kind controls beriberi |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107582805A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111700965A (en) * | 2020-08-09 | 2020-09-25 | 仲崇允 | A Chinese medicinal external preparation for treating fungal infection |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100615568B1 (en) * | 2003-08-26 | 2007-04-12 | 한상룡 | composite of including pyroligneous acid and peppermint oil for skin disease and method of making the same |
CN103263564A (en) * | 2013-04-24 | 2013-08-28 | 景宁畲艺坊服饰有限公司 | Drug for treating dermatophytosis |
CN103961539A (en) * | 2014-05-16 | 2014-08-06 | 湖州康企药业有限公司 | Medicament for treating dermatophytosis |
CN104147584A (en) * | 2014-09-07 | 2014-11-19 | 吴俊� | Medicine for treating beriberi and manufacturing method thereof |
-
2017
- 2017-10-19 CN CN201710978962.8A patent/CN107582805A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100615568B1 (en) * | 2003-08-26 | 2007-04-12 | 한상룡 | composite of including pyroligneous acid and peppermint oil for skin disease and method of making the same |
CN103263564A (en) * | 2013-04-24 | 2013-08-28 | 景宁畲艺坊服饰有限公司 | Drug for treating dermatophytosis |
CN103961539A (en) * | 2014-05-16 | 2014-08-06 | 湖州康企药业有限公司 | Medicament for treating dermatophytosis |
CN104147584A (en) * | 2014-09-07 | 2014-11-19 | 吴俊� | Medicine for treating beriberi and manufacturing method thereof |
Non-Patent Citations (1)
Title |
---|
会员101382111: "去年脚上长了脚气用干薄荷泡水治好了,今年...", 《寻医问药,HTTP://CLUB.XYWY.COM/STATIC/20160712/112419581.HTM》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111700965A (en) * | 2020-08-09 | 2020-09-25 | 仲崇允 | A Chinese medicinal external preparation for treating fungal infection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103142953A (en) | Foot-bath health-protective Chinese medicament powder | |
JP4302534B2 (en) | Dermatitis treatment lotion | |
CN109364226A (en) | A kind of active relaxing muscles and tendons of moisturizing is releived the ancient method plants essential oil ached and preparation method | |
CN104523969A (en) | Medicine for treating arthromyodynia due to kidney-yang deficiency | |
CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
CN107998349A (en) | A kind of external application mud moxibustion and preparation method thereof | |
CN102920802A (en) | Foot bath prescription for home health care | |
KR20110138459A (en) | Herb medicine composition | |
CN100566702C (en) | Liquid medicine in the health care of a kind of bath foot | |
CN107582805A (en) | One kind controls beriberi | |
CN104983928A (en) | Steam-bath health steaming medical package containing agilawood | |
CN103520690A (en) | Foot bathing powder for relaxing muscles and joints, dredging collaterals and reducing pressure | |
CN105561270A (en) | Analgesic Chinese herbal medicine for external application and preparation method thereof | |
CN105616653A (en) | Traditional Chinese medicine composition for treating prickly heat | |
CN105616643A (en) | Traditional Chinese medicinal treatment liquid for treating erosive psoriasis | |
CN103520687A (en) | Bath foot powder for inhibiting fungi | |
CN103263564B (en) | Drug for treating dermatophytosis | |
CN102755530B (en) | Traditional Chinese medicine composition for treating diabetic foot and application thereof | |
CN102949483A (en) | Foot-bath liquid for moistening lung and beautifying | |
CN102949466A (en) | Foot bathing liquid for yang promotion and solid doff | |
CN107951930A (en) | It is a kind of to be used to treat spray of allergic rhinitis and preparation method thereof | |
CN102824456A (en) | Specific medicine for treating animal aftosa | |
CN102441096B (en) | Disperse blood stasis and dredge collateral compound recipe pill and preparation method thereof | |
CN110179956B (en) | Traditional Chinese medicine external lotion for treating hyperhidrosis erosive beriberi | |
CN107096017A (en) | Treat dermopathic external medicine composition and its application method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180116 |
|
WD01 | Invention patent application deemed withdrawn after publication |